Related Experiment Video
Updated: Oct 2, 2025

13:24
Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
11.9K
Assessment of Microsatellite Instability from Next-Generation Sequencing Data
Victor Renault1, Emmanuel Tubacher1, Alexandre How-Kit2
1Laboratory for Bioinformatics, Foundation Jean Dausset - CEPH, Paris, France.
Advances in Experimental Medicine and Biology
|March 1, 2022
Summary
Microsatellite instability (MSI) detection using next-generation sequencing (NGS) offers advantages over traditional methods. This approach aids in cancer diagnosis, prognosis, and predicting response to immunotherapy.
Area of Science:
- Oncology
- Genetics
- Bioinformatics
Background:
- Microsatellite instability (MSI) is a hallmark of DNA mismatch repair deficiency, observed across numerous cancer types.
- MSI status provides prognostic information and predicts response to immune checkpoint blockade therapy.
- Traditional MSI detection methods include PCR and capillary electrophoresis.
Purpose of the Study:
- To review and compare various computational approaches for assessing MSI from next-generation sequencing (NGS) data.
- To highlight the advantages and drawbacks of different NGS-based MSI detection strategies.
- To discuss the clinical applications of NGS for MSI analysis in precision oncology.
Main Methods:
- Review of computational algorithms for MSI detection using NGS data.
- Analysis of different microsatellite panels employed in NGS-based MSI assessment.
- Evaluation of NGS methods against established techniques like PCR.
Main Results:
- NGS offers a versatile platform for MSI detection, potentially analyzing more microsatellites than traditional methods.
- Development of robust computational algorithms is crucial for accurate MSI analysis from NGS data.
- NGS facilitates the simultaneous analysis of MSI and other genetic alterations for comprehensive cancer profiling.
Conclusions:
- NGS-based MSI detection is a promising technology for diverse clinical applications in oncology.
- Further development of bioinformatics tools is essential to fully leverage NGS for MSI assessment.
- NGS-based MSI analysis supports precision oncology by providing prognostic and predictive biomarkers.

